FdaApplication
ANDA 218979
Identifiers
- fda_app_no: ANDA218979
Properties
| Property | Value |
|---|---|
| applicant_name | TWI PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2024-10-28 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| KLOR-CON | POTASSIUM CHLORIDE | 10MEQ | TABLET, EXTENDED RELEASE;ORAL |
| KLOR-CON | POTASSIUM CHLORIDE | 8MEQ | TABLET, EXTENDED RELEASE;ORAL |
2 products